Apoptosis of human esophageal squamous cancer cells induced by RNA interference targeting HIF1α plus cisplatin
Hongyin Liao, Jiangping Song, Lijia Gu
Abstract
Hongyin Liao, Jiangping Song, Lijia Gu
Abstract
Objective To study the effect of HIF-lα siRNA combined with cisplatin on apoptosis of human esophageal squamous cancer cells. Methods siRNA targeting HIF-lα (siRNA-HIF-lα) was constructed. TE-1 cells in vitro were divided into four groups:group A treated with normal saline,group B with cisplatin,group C with siRNA-HIF-lα,and group D with siRNA-HIF-lα and cisplatin.The apoptosis of TE-1 cells were determined by flow cytometry. The expression of HIF-lα mRNA and protein was detected by RT-PCR and Western-blot,respectively. Results The expression of HIF-lα mRNA in groups A, B,C and D was (0.5325 ±0.0809) ,(0.5003 ±0.0726) ,(0.0986 ±0.0171) and (0.0849 ±0.0133) respectively; the expression of HIF-lα protein in groups A,B,C,and D was (0.7280 ±0.0268), (0.7115 ± 0.1293) ,(0.2362 ±0. 0266) and (0. 1917 ±0. 0234) respectively. There was significant difference between group D and groups A,B (P 0.05).The apoptois index in groups A,B,C and D was (3.23 ±0.61)% ,(29. 88 ± 3.48) % , (34.48 ± 5.69) % and (56. 37 ± 7. 99) % . There was significant difference between group D and other three control groups (P<0.01). Conclusion siRNA-HIF-α can significantly increase the cytotoxicity of cisplatin, increase apoptosis of TE-1 cells, and improve the effectiveness of chemotherapy. Key words: Esophageal neoplasm; RNA interference; HIF-lα; Cisplatin; Apoptosis
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the effect of HIF-lα siRNA combined with cisplatin on apoptosis of human esophageal squamous cancer cells. Methods siRNA targeting HIF-lα (siRNA-HIF-lα) was constructed. TE-1 cells in vitro were divided into four groups:group A treated with normal saline,group B with cisplatin,group C with siRNA-HIF-lα,and group D with siRNA-HIF-lα and cisplatin.The apoptosis of TE-1 cells were determined by flow cytometry. The expression of HIF-lα mRNA and protein was detected by RT-PCR and Western-blot,respectively. Results The expression of HIF-lα mRNA in groups A, B,C and D was (0.5325 ±0.0809) ,(0.5003 ±0.0726) ,(0.0986 ±0.0171) and (0.0849 ±0.0133) respectively; the expression of HIF-lα protein in groups A,B,C,and D was (0.7280 ±0.0268), (0.7115 ± 0.1293) ,(0.2362 ±0. 0266) and (0. 1917 ±0. 0234) respectively. There was significant difference between group D and groups A,B (P 0.05).The apoptois index in groups A,B,C and D was (3.23 ±0.61)% ,(29. 88 ± 3.48) % , (34.48 ± 5.69) % and (56. 37 ± 7. 99) % . There was significant difference between group D and other three control groups (P<0.01). Conclusion siRNA-HIF-α can significantly increase the cytotoxicity of cisplatin, increase apoptosis of TE-1 cells, and improve the effectiveness of chemotherapy. Key words: Esophageal neoplasm; RNA interference; HIF-lα; Cisplatin; Apoptosis
Key concepts: Cisplatin, Apoptosis, Western blot, Esophageal cancer, Flow cytometry, Messenger RNA, Molecular biology, Small interfering RNA